In the Company's agreement with the 3PL, the Company acts as principal because it retains control of the product. Once the product is delivered to the Company's specialty pharmacy, the specialty phar…
and divert our management’s attention from the operation of our business. Moreover, achieving and sustaining compliance with applicable federal and state privacy, security and fraud laws may prove co…
Soleno Therapeutics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
SLNO-DEBT
Debt stack $54.3M
90%
Market cache reports total debt of $54.3M.
SLNO-DEBT-12594
Warrants outstanding: 4439000
90%
xbrl warrant detail from xbrl 2026-03-31.
SLNO-DEBT-12595
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2018-06-30.
Soleno Therapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Soleno Therapeutics, Inc..
Soleno Therapeutics, Inc. Ownership
Holder
Name
Confidence
Evidence
SLNO-OWNER-JANUS-HENDERSON-GROUP-PLC
JANUS HENDERSON GROUP PLC
90%
13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 228 tracked holders.
Soleno Therapeutics, Inc. Extended Supply Chain Network